170 related articles for article (PubMed ID: 30429375)
1. Dysregulated NK cell PLCγ2 signaling and activity in juvenile dermatomyositis.
Throm AA; Alinger JB; Pingel JT; Daugherty AL; Pachman LM; French AR
JCI Insight; 2018 Nov; 3(22):. PubMed ID: 30429375
[TBL] [Abstract][Full Text] [Related]
2. Expansion of a novel population of NK cells with low ribosome expression in juvenile dermatomyositis.
Hilliard KA; Throm AA; Pingel JT; Saucier N; Zaher HS; French AR
Front Immunol; 2022; 13():1007022. PubMed ID: 36389718
[TBL] [Abstract][Full Text] [Related]
3. Transcriptomes of peripheral blood mononuclear cells from juvenile dermatomyositis patients show elevated inflammation even when clinically inactive.
Roberson EDO; Mesa RA; Morgan GA; Cao L; Marin W; Pachman LM
Sci Rep; 2022 Jan; 12(1):275. PubMed ID: 34997119
[TBL] [Abstract][Full Text] [Related]
4. Elevated type I IFN signalling directly affects CD8
Huang B; Li H; Jiang Q; Li Y; Jiang Z; Cao H; Wang S; Wang X; Li J; Li G
J Autoimmun; 2024 Jun; 146():103232. PubMed ID: 38692172
[TBL] [Abstract][Full Text] [Related]
5. Multi-Modal Single-Cell Sequencing Identifies Cellular Immunophenotypes Associated With Juvenile Dermatomyositis Disease Activity.
Neely J; Hartoularos G; Bunis D; Sun Y; Lee D; Kim S; Ye CJ; Sirota M
Front Immunol; 2022; 13():902232. PubMed ID: 35799782
[TBL] [Abstract][Full Text] [Related]
6. Coordinated immune dysregulation in juvenile dermatomyositis revealed by single-cell genomics.
Rabadam G; Wibrand C; Flynn E; Hartoularos GC; Sun Y; Madubata C; Fragiadakis GK; Ye CJ; Kim S; Gartner ZJ; Sirota M; Neely J
JCI Insight; 2024 May; 9(12):. PubMed ID: 38743491
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal peripheral blood lymphocyte subsets correlate with decreased disease activity in juvenile dermatomyositis.
Ernste FC; Crowson CS; de Padilla CL; Hein MS; Reed AM
J Rheumatol; 2013 Jul; 40(7):1200-11. PubMed ID: 23678152
[TBL] [Abstract][Full Text] [Related]
8. Phospholipase Cγ2 is critical for Ca
Peng X; Zhao G; Lin J; Qu J; Zhang Y; Li C
BMC Ophthalmol; 2018 Jul; 18(1):170. PubMed ID: 30005593
[TBL] [Abstract][Full Text] [Related]
9. Phospholipase C-gamma 2 is a critical signaling mediator for murine NK cell activating receptors.
Tassi I; Presti R; Kim S; Yokoyama WM; Gilfillan S; Colonna M
J Immunol; 2005 Jul; 175(2):749-54. PubMed ID: 16002670
[TBL] [Abstract][Full Text] [Related]
10. Increased Fas and Bcl-2 expression on peripheral blood T and B lymphocytes from juvenile-onset systemic lupus erythematosus, but not from juvenile rheumatoid arthritis and juvenile dermatomyositis.
Liphaus BL; Kiss MH; Carrasco S; Goldenstein-Schainberg C
Clin Dev Immunol; 2006; 13(2-4):283-7. PubMed ID: 17162369
[TBL] [Abstract][Full Text] [Related]
11. Juvenile dermatomyositis: the association of the TNF alpha-308A allele and disease chronicity.
Pachman LM; Fedczyna TO; Lechman TS; Lutz J
Curr Rheumatol Rep; 2001 Oct; 3(5):379-86. PubMed ID: 11564368
[TBL] [Abstract][Full Text] [Related]
12. Swiprosin-1/EFhd2 controls B cell receptor signaling through the assembly of the B cell receptor, Syk, and phospholipase C gamma2 in membrane rafts.
Kroczek C; Lang C; Brachs S; Grohmann M; Dütting S; Schweizer A; Nitschke L; Feller SM; Jäck HM; Mielenz D
J Immunol; 2010 Apr; 184(7):3665-76. PubMed ID: 20194721
[TBL] [Abstract][Full Text] [Related]
13. Muscle abnormalities in juvenile dermatomyositis patients: P-31 magnetic resonance spectroscopy studies.
Park JH; Niermann KJ; Ryder NM; Nelson AE; Das A; Lawton AR; Hernanz-Schulman M; Olsen NJ
Arthritis Rheum; 2000 Oct; 43(10):2359-67. PubMed ID: 11037897
[TBL] [Abstract][Full Text] [Related]
14. Decreased levels of CD54 (ICAM-1)-positive lymphocytes in the peripheral blood in untreated patients with active juvenile dermatomyositis.
O'Gorman MR; Bianchi L; Zaas D; Corrochano V; Pachman LM
Clin Diagn Lab Immunol; 2000 Jul; 7(4):693-7. PubMed ID: 10882674
[TBL] [Abstract][Full Text] [Related]
15. Magnesium abnormalities of skeletal muscle in dermatomyositis and juvenile dermatomyositis.
Niermann KJ; Olsen NJ; Park JH
Arthritis Rheum; 2002 Feb; 46(2):475-88. PubMed ID: 11840451
[TBL] [Abstract][Full Text] [Related]
16. Plasma exosomes from children with juvenile dermatomyositis are taken up by human aortic endothelial cells and are associated with altered gene expression in those cells.
Jiang K; Karasawa R; Hu Z; Chen Y; Holmes L; O'Neil KM; Jarvis JN
Pediatr Rheumatol Online J; 2019 Jul; 17(1):41. PubMed ID: 31299993
[TBL] [Abstract][Full Text] [Related]
17. Natural and antibody-dependent cellular cytotoxicity in children with systemic lupus erythematosus and juvenile dermatomyositis.
Miller ML; Lantner R; Pachman LM
J Rheumatol; 1983 Aug; 10(4):640-2. PubMed ID: 6620266
[TBL] [Abstract][Full Text] [Related]
18. Mineral metabolism in children with dermatomyositis.
Perez MD; Abrams SA; Koenning G; Stuff JE; O'Brien KO; Ellis KJ
J Rheumatol; 1994 Dec; 21(12):2364-9. PubMed ID: 7699644
[TBL] [Abstract][Full Text] [Related]
19. Updates on efficacy and safety janus kinase inhibitors in juvenile dermatomyositis.
Kim H
Expert Rev Clin Immunol; 2024 Jun; 20(6):589-602. PubMed ID: 38299575
[TBL] [Abstract][Full Text] [Related]
20. MHC class I and II expression in juvenile dermatomyositis skeletal muscle.
Sallum AM; Kiss MH; Silva CA; Wakamatsu A; Sachetti S; Lotufo S; Matsumura N; Marie SK
Clin Exp Rheumatol; 2009; 27(3):519-26. PubMed ID: 19604449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
